July 5, 2016 04:33 PM EDTUpdated July 10, 02:16 PM

Using money honey instead of threats, Sanofi wins a seat at the bargaining table for Medivation buyout

It took a sweeter bid and a CVR for its experimental therapy talazoparib, but Sanofi $SNY can now take a seat at the bargaining table …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Us­ing mon­ey hon­ey in­stead of threats, Sanofi wins a seat at the bar­gain­ing ta­ble for Medi­va­tion buy­out